HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
manganese mesoporphyrin
MRI contrast medium
Also Known As:
Mn-mesoporphyrin
Networked:
2
relevant articles (
0
outcomes,
0
trials/studies)
Bio-Agent Context: Research Results
Heterocyclic Compounds: 198
1-Ring Heterocyclic Compounds
Azoles: 2138
Pyrroles: 369
Tetrapyrroles: 70
Porphyrins: 3316
Mesoporphyrins: 3
manganese mesoporphyrin: 2
Fused-Ring Heterocyclic Compounds
4 or More Rings Heterocyclic Compounds
Tetrapyrroles: 70
Porphyrins: 3316
Mesoporphyrins: 3
manganese mesoporphyrin: 2
Polycyclic Compounds: 6
Macrocyclic Compounds: 15
Tetrapyrroles: 70
Porphyrins: 3316
Mesoporphyrins: 3
manganese mesoporphyrin: 2
Biological Factors: 2472
Biological Pigments: 1
Porphyrins: 3316
Mesoporphyrins: 3
manganese mesoporphyrin: 2
Related Diseases
1.
Neoplasms (Cancer)
01/01/1995 - "
Analysis of tissue Mn levels 100 min after i.v. Mn-mesoporphyrin injection demonstrated preferential distribution of Mn to normal liver tissue (57.8 +/- 15.3 micrograms Mn/g) compared with VX-2 tumor (4.28 +/- 1.48 micrograms Mn/g).
"
01/01/1995 - "
I.v. administration of 0.04 mmol/kg (25 mg/kg) Mn-mesoporphyrin resulted in improvement of tumor-to-liver contrast, with enhancement of normal liver (99.7 +/- 14.7%) and the gallbladder (442 +/- 116%), but not VX-2 tumor tissue (14.8 +/- 13.9%), (n = 8, p = .05).
"
2.
Liver Diseases (Liver Disease)
07/01/1992 - "
At an intravenous dose of 0.035 mmol/kg, Mn-mesoporphyrin caused significant enhancement of normal liver parenchyma and increased the lesion-to-liver contrast in both the models of heptic liver abscess and metastatic liver disease.
"
3.
Liver Abscess
07/01/1992 - "
At an intravenous dose of 0.035 mmol/kg, Mn-mesoporphyrin caused significant enhancement of normal liver parenchyma and increased the lesion-to-liver contrast in both the models of heptic liver abscess and metastatic liver disease.
"
4.
Carcinoma (Carcinomatosis)
01/01/1995 - "
Rabbits given VX-2 carcinoma liver implants (n = 8) were imaged before and after the intravenous (i.v.) administration of 0.04 mmol/kg Mn-mesoporphyrin.
"
01/01/1995 - "
Intravenous manganese-mesoporphyrin as a magnetic resonance imaging contrast agent: an experimental model using VX-2 carcinoma in rabbits.
"
01/01/1995 - "
We investigated the potential of manganese (III) mesoporphyrin (Mn-mesoporphyrin) as a hepatobiliary contrast agent for magnetic resonance (MR) imaging in rabbits given VX-2 carcinoma liver implants.
"
Related Drugs and Biologics
1.
Manganese
2.
Contrast Media
3.
mesoporphyrin IX